These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9443670)

  • 1. In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir).
    Xiong X; Flores C; Fuller MD; Mendel DB; Mulato AS; Moon K; Chen MS; Cherrington JM
    Antiviral Res; 1997 Nov; 36(2):131-7. PubMed ID: 9443670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine.
    Foster SA; Cerny J; Cheng YC
    J Biol Chem; 1991 Jan; 266(1):238-44. PubMed ID: 1845964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.
    Starrett JE; Tortolani DR; Hitchcock MJ; Martin JC; Mansuri MM
    Antiviral Res; 1992 Sep; 19(3):267-73. PubMed ID: 1332606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.
    Balzarini J; Hao Z; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1499-503. PubMed ID: 1705039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.
    Perno CF; Balestra E; Aquaro S; Panti S; Cenci A; Lazzarino G; Tavazzi B; Di Pierro D; Balzarini J; Calio R
    Mol Pharmacol; 1996 Aug; 50(2):359-66. PubMed ID: 8700144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
    Foli A; Sogocio KM; Anderson B; Kavlick M; Saville MW; Wainberg MA; Gu Z; Cherrington JM; Mitsuya H; Yarchoan R
    Antiviral Res; 1996 Oct; 32(2):91-8. PubMed ID: 8891168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro.
    Cherrington JM; Mulato AS; Fuller MD; Chen MS
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2212-6. PubMed ID: 8878611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.
    Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G
    J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
    Ruiz JC; Beadle JR; Aldern KA; Keith KA; Hartline CB; Kern ER; Hostetler KY
    Antiviral Res; 2007 Jul; 75(1):87-90. PubMed ID: 17367874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
    Cerny J; Foster SA; Cheng YC
    Mol Pharmacol; 1992 Sep; 42(3):537-44. PubMed ID: 1328849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.
    Fu X; Jiang S; Li C; Xin J; Yang Y; Ji R
    Bioorg Med Chem Lett; 2007 Jan; 17(2):465-70. PubMed ID: 17074481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of antiviral acyclic nucleoside phosphonate 9-[2-(phosphonomethoxy)ethyl]adenine (adefovir) on cytochrome P450 system of rat liver microsomes.
    Zídek Z; Anzenbacher P; Anzenbacherová E; Buchar E; Kmonícková E; Potmesil P; Holý A
    J Biomed Sci; 2006 May; 13(3):295-301. PubMed ID: 16416053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    Snoeck R; Andrei G; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human immunodeficiency virus(HIV) inhibitor 9-(2-phosphonylmethoxyethyl)adenine (PMEA) is a strong inducer of differentiation of several tumor cell lines.
    Balzarini J; Verstuyf A; Hatse S; Goebels J; Sobis H; Vandeputte M; De Clercq E
    Int J Cancer; 1995 Mar; 61(1):130-7. PubMed ID: 7705926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibilities of zidovudine-resistant variants of human immunodeficiency virus type 1 to inhibition by acyclic nucleoside phosphonates.
    Gong YF; Marshall DR; Srinivas RV; Fridland A
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1683-7. PubMed ID: 7979311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency metabolism and activity against human immunodeficiency virus or herpes simplex virus.
    Perno CF; Santoro N; Balestra E; Aquaro S; Cenci A; Lazzarino G; Di Pierro D; Tavazzi B; Balzarini J; Garaci E; Grimaldi S; Caliò R
    Antiviral Res; 1997 Feb; 33(3):153-64. PubMed ID: 9037372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo.
    Neyts J; Stals F; Bruggeman C; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):437-46. PubMed ID: 8395382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
    Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model.
    Hatse S; Naesens L; De Clercq E; Balzarini J
    Biochem Pharmacol; 1998 Oct; 56(7):851-9. PubMed ID: 9774147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordination Chemistry of Nucleotides and Antivirally Active Acyclic Nucleoside Phosphonates, including Mechanistic Considerations.
    Sigel A; Sigel H; Sigel RKO
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35565975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.